磷酸化血管生成素受体2抗体

Quantity size:

0.1ml

Concentration:

1mg/ml 磷酸化血管生成素受体2抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

The TEK receptor tyrosine kinase is expressed almost exclusively in endothelial cells in mice, rats, and humans. This receptor possesses a unique extracellular domain containing 2 immunoglobulin-like loops separated by 3 epidermal growth factor-like repeats that are  磷酸化血管生成素受体2抗体connected to 3 fibronectin type III-like repeats. The ligand for the receptor is angiopoietin-1. Defects in TEK are associated with inherited venous malformations; the TEK signaling pathway appears to be critical for endothelial cell-smooth muscle cell communication in venous morphogenesis.TEK is closely related to the TIE receptor tyrosine kinase.

 磷酸化血管生成素受体2抗体Also known as:

Tie-2; Tie2; Tek; Angiopoietin-1 receptor; Tyrosine-protein kinase receptor TIE-2; hTIE2; Tyrosine-protein kinase receptor TEK; Tunica interna endothelial cell kinase; p140 TEK; Angiopoietin 1 receptor; CD202b; CD202b antigen; Endothelial tyrosine kinase; Endothelium specific receptor tyrosine kinase 2; hTIE 2; Hyk; Soluble TIE2 variant 1; Soluble TIE2 variant 2; tek tyrosine kinase; TEK tyrosine kinase endothelial; tek tyrosine kinase, endothelial; TIE 2; TIE2_HUMAN; Tunica interna endothelial cell kinase; Tyrosine kinase with Ig and EGF homology domains 2; Tyrosine protein kinase 磷酸化血管生成素受体2抗体 receptor TEK; Tyrosine protein kinase receptor TIE 2; Tyrosine-protein kinase receptor TIE-2; Venous malformations multiple cutaneous and mucosal; VMCM 1; VMCM; VMCM1; CD202b.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep, .

●

Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Tie2 around  磷酸化血管生成素受体2抗体the phosphorylation site of Ser1119.

●

Predicted Molecular Weight: 124kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user

kl253Hu01麦芽糖酶糖化酶(MGA)多克隆抗体Polyclonal Antibody to Maltase Glucoamylase, Intestinal (MGA)

kl259Bo01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)

kl259Ga01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)

kl259Hu01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)

kl259Mu01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)

kl259Ra01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)

kl259Si01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)

kl260Si01β2-微球蛋白(β2M)多克隆抗体Polyclonal Antibody to Beta-2-Microglobulin (b2M)

kl262Hu01转铁蛋白受体2(TFR2)多克隆抗体Polyclonal Antibody to Transferrin Receptor 2 (TFR2)

kl262Mu01转铁蛋白受体2(TFR2)多克隆抗体Polyclonal Antibody to Transferrin Receptor 2 (TFR2)

kl262Ra01转铁蛋白受体2(TFR2)多克隆抗体Polyclonal Antibody to Transferrin Receptor 2 (TFR2)

kl263Bo01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)

kl263Ga01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)

kl263Hu01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)

kl263Mu01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)

kl263Po01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)

kl266Hu01热休克蛋白47(HSP47)多克隆抗体Polyclonal Antibody to Heat Shock Protein 47 (HSP47)

kl267Bo01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)

kl267Ca01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)

kl267Ga01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)

kl267Hu01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)

kl267Mu01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)

kl267Po01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)

kl267Ra01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)

.